Questions? Feedback? powered by Olark live chat software

ADHD Drugs Might Soon Be Used To Treat Binge Eat

Tue, November 5th, 2013 LONDON (Reuters) - Pharmaceutical group Shire PLC said Vyvanse, its amphetamine-based drug prescribed for ADHD, had also been successful in treating the newly-recognized binge eating disorder (BED) in a trial. BED affects 2.8 percent of U.S. adults in their lifetime and it is characterized by recurring episodes of binge eating, feeling out of control while bingeing, and feeling guilt and shame afterwards. According to Dr. Levinson's clinically based research, stimulant and other impulse controlling medications can be helpful for a wide range of impulse disorders, especially when associated with ADHD. These medications provide patients with added control over many of their emotional, behavioral social and higher functioning. nson, M.D.

Formerly Clinical Associate Professor of Psychiatry at New York University Medical Center, Dr. Harold Levinson is currently Director of the Levinson Medical Center for Learning Disabilities in Great Neck, New York. He is a well known neuropsychiatrist, clinical researcher and author. His "highly original" research into the cerebellar-vestibular (inner-ear) origins and treatment of dyslexia and related learning, attention-deficit/hyperactivity and anxiety or phobic disorders has evolved over the past four decades. Levinson's concepts encompass the collective insights derived from the examinations, follow-up and successful treatment of over 35,000 children, adults and even seniors and have led to new methods of screening, diagnosis, treatment and prevention. His expanded theories appear capable of encompassing and/or explaining all reported symptoms as well as most other concepts and experimental data, thus resulting in a truly holistic perspective.

For more information, call 1(800) 334-7323 or visit